CBD is one of many compounds, known as cannabinoids, in the cannabis plant. Researchers have been looking at the possible therapeutic uses of CBD. CBD oils are oils that contain concentrations of CBD. The concentrations and the uses of these oils vary.
Until recently, the best-known compound in cannabis was delta-9 tetrahydrocannabinol (THC). This is the most active ingredient in marijuana.
Marijuana contains both THC and CBD, and these compounds have different effects. THC creates a mind-altering “high” when a person smokes it or uses it in cooking. This is because THC breaks down when we apply heat and introduce it into the body.
CBD is different. Unlike THC, it is not psychoactive. This means that CBD does not change a person’s state of mind when they use it. However, CBD does appear to produce significant changes in the body, and some research suggests that it has medical benefits.
All cannabinoids, including CBD, produce effects in the body by attaching to certain receptors. The human body produces certain cannabinoids on its own. It also has two receptors for cannabinoids, called the CB1 receptors and CB2 receptors.
CB1 receptors are present throughout the body, but many are in the brain. The CB1 receptors in the brain deal with coordination and movement, pain, emotions, and mood, thinking, appetite, and memories, and other functions. THC attaches to these receptors.
CB2 receptors are more common in the immune system. They affect inflammation and pain.
Researchers once believed that CBD attached to these CB2 receptors, but it now appears that CBD does not attach directly to either receptor. Instead, it seems to direct the body to use more of its own cannabinoids.High amounts of the Cannabinoid “CBG” or Cannabigerol have been shown to be more copasetic to the effectiveness of the CBD.
Hemp oil and the constituents contained within it are not soluble in the human digestive tract, therefore if you are using a CBD oil product that is still in it’s oil based form, then your body is only absorbing 10% or less of the active CBD. Since our bodies are mostly water (70%+), water-soluble compounds travel through the body and are uptake far more efficiently. The latest studies show that a water soluble CBD products have a 90-95% uptake rate in the body, as opposed to the 10% uptake rate of an oil based CBD product. (Please note that all UltraLifeSport ingestible products are made with 100% water soluble compounds, not just the CBD, but the full spectrum of Cannabinoids along with all other compounds found within our capsules. Our ingredients are also nano-particle sized and compounded with trace minerals to further help in absorption and uptake, in turn having maximum effectiveness of the active compounds in the body).
The least processed form of the cannabis plant is hemp. Hemp contains most of the CBD that people use medicinally. Hemp and marijuana come from the same plant, Cannabis sativa, but the two are very different.
Over the years, marijuana farmers have selectively bred their plants to contain high levels of THC and other compounds that interested them, often because the compounds produced a smell or had another effect on the plant’s flowers.
However, hemp farmers have rarely modified the plant. These hemp plants are used to create CBD oil.
People tend to use prescription or over-the-counter drugs to relieve stiffness and pain, including chronic pain.
Some people believe that CBD offers a more natural alternative.
Authors of a study published in the Journal of Experimental Medicine found that CBD significantly reduced chronic inflammation and pain in some mice and rats.
The researchers suggested that the non-psychoactive compounds in marijuana, such as CBD, could provide a new treatment for chronic pain.
Some promising evidence suggests that CBD use may help people to quit smoking.
A pilot study published in Addictive Behaviors found that smokers who used inhalers containing CBD smoked fewer cigarettes than usual and had no further cravings for nicotine.
A similar review, published in Neurotherapeutics found that CBD may be a promising treatment for people with opioid addiction disorders.
The researchers noted that CBD reduced some symptoms associated with substance use disorders. These included anxiety, mood-related symptoms, pain, and insomnia.
More research is necessary, but these findings suggest that CBD may help to prevent or reduce withdrawal symptoms.
After researching the safety and effectiveness of CBD oil for treating epilepsy, the FDA approved the use of CBD (Epidiolex) as a therapy for two rare conditions characterized by epileptic seizures in 2018.
In the U.S., a doctor can prescribe Epidiolex to treat:
Lennox-Gastaut syndrome (LGS), a condition that appears between the ages of 3 and 5 years and involves different kinds of seizures Dravet syndrome (DS), a rare genetic condition that appears in the first year of life and involves frequent, fever-related seizures.
The types of seizures that characterize LGS or DS are difficult to control with other types of medication.
The FDA specified that doctors could not prescribe Epidiolex for children younger than 2 years. A physician or pharmacist will determine the right dosage based on body weight.
Researchers are studying the effects of CBD on various neuropsychiatric disorders.
Authors of a 2014 review noted that CBD has anti-seizure properties and a low risk of side effects for people with epilepsy.
Findings suggested that CBD may also treat many complications linked to epilepsy, such as neurodegeneration, neuronal injury, and psychiatric diseases.
Another study, published in Current Pharmaceutical Design, found that CBD may produce effects similar to those of certain antipsychotic drugs, and that the compound may provide a safe and effective treatment for people with schizophrenia. However, further research is necessary.
Some researchers have found that CBD may prove to combat cancer.
Authors of a review published in the British Journal of Clinical Pharmacology found evidence that CBD significantly helped to prevent the spread of cancer.
The researchers also noted that the compound tends to suppress the growth of cancer cells and promote their destruction.
They pointed out that CBD has low levels of toxicity. They called for further research into its potential as an accompaniment to standard cancer treatments.
Doctors often advise people with chronic anxiety to avoid cannabis, as THC can trigger or amplify feelings of anxiousness and paranoia.
However, authors of a review from Neurotherapeutics found that CBD may help to reduce anxiety in people with certain related disorders.
According to the review, CBD may reduce anxiety-related behaviors in people with conditions such as:
• post-traumatic stress disorder • general anxiety disorder • panic disorder • social anxiety disorder • obsessive-compulsive disorder
The authors noted that current treatments for these disorders can lead to additional symptoms and side effects, which can cause some people to stop taking them.
No further definitive evidence currently links CBD to adverse effects, and the authors called for further studies of the compound as a treatment for anxiety.
Acne treatment is another promising use for CBD. The condition is caused, in part, by inflammation and overworked sebaceous glands in the body.
A 2014 study published by the Journal of Clinical Investigation found that CBD helps to lower the production of sebum that leads to acne, partly because of its anti-inflammatory effect on the body. Sebum is an oily substance, and overproduction can cause acne.
CBD could become a future treatment for acne vulgaris, the most common form of acne.
Type 1 diabetes results from inflammation that occurs when the immune system attacks cells in the pancreas.
Research published in 2016 by Clinical Hemorheology and Microcirculation found that CBD may ease this inflammation in the pancreas. This may be the first step in finding a CBD-based treatment for type 1 diabetes.
A paper presented in the same year in Lisbon, Portugal, suggested that CBD may reduce inflammation and protect against or delay the development of type 1 diabetes.
Initial research published in the Journal of Alzheimer’s Disease found that CBD was able to prevent the development of social recognition deficit in participants.
This means that CBD could help people in the early stages of Alzheimer’s to keep the ability to recognize the faces of people that they know.
This is the first evidence that CBD may slow the progression of Alzheimer’s disease.
Many small-scale studies have looked into the safety of CBD in adults. They concluded that adults tend to tolerate a wide range of doses well.Researchers have found no significant side effects on the central nervous system, the vital signs, or mood, even among people who used high dosages.
Most animal studies with cannabidiol utilize synthetic, single-molecule CBD produced by biochemical laboratories for research purposes. In contrast, whole plant extractions typically include CBD, THC, and more than 400 trace compounds. It is thought that many of these compounds interact synergistically to create what scientists refer to as an “entourage effect” that magnifies the therapeutic benefits of the plant’s individual components—so that the medicinal impact of the whole plant is greater than the sum of its parts.
It is important to consider the entourage effect (or lack thereof) when extrapolating data based on animal studies: It was originally thought that having all the Cannabinoids including THC present was needed for the “entourage effect”, but the latest studies are showing that it looks to be more about the terpenes than the full spectrum of cannabinoids which creates this “entourage Effect”. The latest studies also show that THC binds to the CB1 receptors first and makes it more difficult for the CBD to bind. High amounts of the CBG molecule have been shown to kick the THC molecules off of the CB1 receptors and bind to all open sites, then acting as a vacuum for the CBD molecules pulling them in more efficiently. So the newest science is telling us that having THC removed from the spectrum of Cannabinoids in a CBD based product, and higher amounts of the CBG molecule are added, then the product is actually more effective overall, if what you are looking for is the actual medicinal effects of CBD.
(Note that all UltraLifeSport products have been formulated taking into account the latest scientific information and contain zero THC. They have high amounts of CBG added to the rest of the full spectrum of Cannabinoids, to make our product the most highly effective on the market).
Consider the role of terpenes, for example. Terpenes are volatile aromatic molecules that evaporate easily and readily announce themselves to the nose. Various researchers have emphasized the pharmacological importance of terpenes, or terpenoids, which form the basis of aromatherapy, a popular holistic healing modality. Marijuana’s compelling fragrance and particular psychoactive flavor are determined by the predominate terpenes in a strain.
Around 200 terpenes have been found in cannabis, but only a few of these odiferous oily substances appear in amounts substantial enough to be noteworthy, or nose worthy, as it were. Among them are monoterpenes, diterpenes, and sesquiterpenes, which are characterized by the number of repeating units of a 5-carbon molecule called isoprene, the structural hallmark of all terpenoid compounds. The terpenes in marijuana have given the plant an enduring, evolutionary advantage. Pungent terpenoid oils repel insects and animal grazers; others prevent fungus.
Terpenes, it turns out, are healthy for people as well as plants. A September 2011 report by Dr. Ethan Russo in the British Journal of Pharmacology discussed the wide-ranging therapeutic attributes of terpenoids, which are typically lacking in “CBD-only” products.
Beta-caryophyllene, for example, is a sesquiterpene found in the essential oil of black pepper, oregano, and other edible herbs, as well as in various cannabis strains and in many green, leafy vegetables. It is gastro-protective, good for treating certain ulcers, and offers great promise as a therapeutic compound for inflammatory conditions and auto-immune disorders because it binds directly to the peripheral cannabinoid receptor known as “CB2.”
In 2008, the Swiss scientist Jürg Gertsch documented beta-caryophyllene’s binding affinity for the CB2receptor and described it as “a dietary cannabinoid.” It is the only terpenoid known to directly activate a cannabinoid receptor. And it’s one of the reasons why green, leafy vegetables are so healthy to eat.
Terpenoids and cannabinoids both increase blood flow, enhance cortical activity, and kill respiratory pathogens, including MRSA, the antibiotic-resistant bacteria that in recent years has claimed the lives of tens of thousands of Americans. Dr. Russo’s article reports that cannabinoid-terpenoid interactions “could produce synergy with respect to treatment of pain, inflammation, depression, anxiety, addiction, epilepsy, cancer, fungal and bacterial infections.”
Marijuana’s bouquet of terpenes—that “riot of perfumes,” as the poet (and hashish-eater) Arthur Rimbaud once said—plays another important role. Terpenes and CBD buffer THC’s tricky psychoactivity. Cannabinoid-terpenoid interactions amplify the beneficial effects of cannabis while mitigating THC-induced anxiety.
The terpenoid profile can vary considerably from strain to strain. Patients who abandon a suitable strain for one with higher THC and/or CBD content may not get more relief if the terpenoid profile is significantly different.